We are live on
!
Find out more
Madrigal Pharmaceuticals
MDGL
MDGL
42 hedge funds and large institutions have $33.3M invested in Madrigal Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 14 increasing their positions, 3 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
367% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 3
111% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 9
41% more capital invested
Capital invested by funds: $23.6M → $33.3M (+$9.74M)
31% more funds holding
Funds holding: 32 → 42 (+10)
3.6% more ownership
Funds ownership: 13.22% → 16.82% (+3.6%)
Holders
42
Holders Change
+10
Holders Change %
+31.25%
% of All Funds
1.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
14
Reduced
3
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$4.92M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$3.13M |
| 3 |
BlackRock
New York
|
+$2.54M |
| 4 |
AC
Armistice Capital
New York
|
+$2.41M |
| 5 |
State Street
Boston,
Massachusetts
|
+$518K |
Top Sellers
| 1 |
Capital World Investors
Los Angeles,
California
|
-$6.7M |
| 2 |
Millennium Management
New York
|
-$486K |
| 3 |
Goldman Sachs
New York
|
-$321K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$181K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$148K |
